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Background: ChIP-Seq is widely used to detect genomic segments bound by transcription factors (TF), either directly
at DNA binding sites (BSs) or indirectly via other proteins. Currently, there are many software tools implementing
different approaches to identify TFBSs within ChIP-Seq peaks. However, their use for the interpretation of ChIP-Seq data
is usually complicated by the absence of direct experimental verification, making it difficult both to set a threshold to
avoid recognition of too many false-positive BSs, and to compare the actual performance of different models.
Results: Using ChIP-Seq data for FoxA2 binding loci in mouse adult liver and human HepG2 cells we compared FoxA
binding-site predictions for four computational models of two fundamental classes: pattern matching based on existing
training set of experimentally confirmed TFBSs (oPWM and SiteGA) and de novo motif discovery (ChIPMunk and diChIP-
Munk). To properly select prediction thresholds for the models, we experimentally evaluated affinity of 64 predicted
FoxA BSs using EMSA that allows safely distinguishing sequences able to bind TF. As a result we identified thousands
of reliable FoxA BSs within ChIP-Seq loci from mouse liver and human HepG2 cells. It was found that the performance
of conventional position weight matrix (PWM) models was inferior with the highest false positive rate. On the contrary,
the best recognition efficiency was achieved by the combination of SiteGA & diChIPMunk/ChIPMunk models, properly
identifying FoxA BSs in up to 90% of loci for both mouse and human ChIP-Seq datasets.
Conclusions: The experimental study of TF binding to oligonucleotides corresponding to predicted sites
increases the reliability of computational methods for TFBS-recognition in ChIP-Seq data analysis. Regarding
ChIP-Seq data interpretation, basic PWMs have inferior TFBS recognition quality compared to the more sophisticated
SiteGA and de novo motif discovery methods. A combination of models from different principles allowed identification
of proper TFBSs.
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Identification of transcription regulatory elements in a
genome is an actively evolving topic in modern molecular
biology. The major class of these elements is represented
by transcription factor (TF) binding sites (TFBSs), short
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immunoprecipitation (ChIP) followed by microarray
hybridization (ChIP-chip) or by massively parallel sequen-
cing (ChIP-Seq), allow genome-scale mapping of TF occu-
pancy in a given cell type and state [1]. To date, thousands
of binding loci for a large number of TFs have been re-
vealed for various cell types [2]. However, both ChIP-Seq
and ChIP-chip technologies are not able to distinguish dir-
ect TF binding to DNA from indirect binding mediated by
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binding) [1,3]. Prediction of the genome-wide TF binding
landscape, i.e. identification of the entire set of TFBSs
existing in a particular genome irrespective to the cell type
and state, is also unlikely to be done without proper TFBS
modeling in silico. Furthermore, ChIP-Seq identifies exact
locations of TFBSs only indirectly and cannot discriminate
between closely spaced multiple sites within DNA seg-
ments of hundreds of base pairs [4].
To identify TFBSs in a given sequence one applies
computational methods for their recognition. A myriad
of such methods exists today, falling into two main clas-
ses [5,6]. The first class is based on pattern matching,
also called motif finding. In this case, the TFBS recogni-
tion model is constructed on an independent training
set of TFBS sequences obtained from conventional gene-
by-gene experimental studies. The pattern is often repre-
sented as a positional weight matrix (PWM) which
assumes that nucleotides in BS sequence additively and
independently contribute to the total binding energy [5].
The PWM is widely used for TFBSs recognition in gen-
omic sequences, e.g. to interpret ChIP-Seq data. A num-
ber of information resources contain the ready-to-use
TFBS matrices, namely, TRANSFAC [7], JASPAR [8],
ARTSITE [9], HOCOMOCO [10] etc. The performance
of conventional PWMs can be improved if dependencies
between adjacent positions are taken into account, e.g.
using so-called dinucleotide PWMs [11]. The next im-
provement of this approach is a proper selection of matrix
length, i.e. construction of optimized PWM (oPWM)
[12,13]. More sophisticated and much less commonly
used methods do not include “the additivity assumption”,
i.e. nucleotides in different positions may depend on each
other [14,15]. Among these methods is our previously de-
veloped SiteGA, well-proven in recognition of various
TFBSs [12].
The second class of methods is oriented towards de
novo pattern detection, and referred to as motif discovery,
also often utilizing PWMs as the TFBS model. Initially,
motif discovery was proposed to identify TFBSs in pro-
moter sequences of co-regulated or orthologous genes. Al-
though motif discovery algorithms have been shown to
work successfully in bacteria and yeast, they performed
significantly worse in higher organisms [16]. However,
the motif discovery approach has become of extremely
high value with the emergence of ChIP-chip/ChIP-Seq
technologies [17,18]. Currently, many variations of such
methods exist, some of them are presented in well-known
resources. ChIPMunk [19] and diChIPMunk [20] belong
to this class. Using the basic PWM model ChIPMunk per-
formed nicely in several independent benchmarks [21,22],
including the recent one of the DREAM consortium [23].
diChIPMunk uses the same engine as ChIPMunk to pro-
duce dinucleotide PWMs.It is of great interest to compare the performance of
the motif discovery and motif finding approaches applied
to the same experimental data. However, no such studies
have been carried out until now. Moreover, a compara-
tive analysis of the advantages and shortcomings of dif-
ferent methods is hampered by the lack of direct
experimental verification of predicted TFBSs.
Using a FoxA2 ChIP-Seq data for mouse adult liver
chromatin [24] and human hepatoma cell line chromatin
[25] we conducted a comparative assessment of oPWM
and SiteGA (pattern-matching models), ChIPMunk, and
diChIPMunk (pattern-detection models), which was ac-
companied by experimental verification.
FoxA2 is a member of the FoxA subfamily of winged
helix/forkhead box (Fox) transcription factors playing
important roles at different stages of mammalian life
cycle, including early development, organogenesis, and
metabolism and homeostasis in the adult [26]. FoxA2
was shown to be a pioneer transcription factor [27], thus
indirect (mediated by other DNA-binding proteins)
binding of FoxA2 to chromatin should not be a major
event. With the independent human and mouse liver
ChIP-Seq datasets available FoxA2 is one of the most con-
venient TFs to compare different computer approaches
for prediction of TFBSs.
Results
Identification of FoxA binding sites in promoter
ChIP-Seq loci
Initially, to compare the performance of pattern match-
ing and pattern detection approaches for TFBS predic-
tion in the context of ChIP-Seq data, we applied oPWM
and SiteGA (as representatives of the former class) as
well as ChIPMunk and diChIPMunk (as representatives
of the latter class) to analyze a dataset of 4455 FoxA2-
binding loci (ChIP-Seq peaks with read coverage of at
least 15) in mouse adult liver chromatin [24].
To produce a subset of data for experimental verifica-
tion we restricted the search to FoxA2-binding loci that
overlapped with 1 kb upstream regions of RefSeq genes
(mm8 assembly) and had coverage at least 15 (301 pro-
moters). Totally 466 putative FoxA BSs were predicted
in these regions. Each BS was characterized by a set of
four scores corresponding to the four models used. The
thresholds applied were very low, so that among selected
putative BSs were those with non-consistent functional-
ity. The pairwise comparison of scores (Figure 1) showed
a good agreement between models of the same class
(pattern match or pattern detection). Thus, there was a
strong correlation between predictions of oPWM/SiteGA
(Figure 1A, Pearson correlation coefficient 0.872) and
ChIPMunk/diChIPMunk (Figure 1B, 0.708). The agree-
ment between other pairs of models was notably lower
(with the highest correlation coefficient of 0.625 for
Figure 1 Scores of different FoxA BS recognition models for TFBSs derived from ChIP-Seq data [24]. Six panels from A to F denote all
possible pairwise combination of ChIPMunk, diChIPMunk, SiteGA and oPWM models. Black dots denote the sample of 466 potential BSs: (A) sites
mapped in promoter regions located in 1000 bp upstream regions of RefSeq genes; (B) binding sites lying in peak regions with peak height of
15 or higher. The 64 BSs selected for experimental verification are shown as grey crossed squares, brown triangles and red circles, corresponding
to the EMSA scores below 0.25 (non-sites), in the range from 0.25 to 0.75 (weak sites) and above 0.75 (strong sites). Solid lines mark the model
thresholds selected to discard non-sites.
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able portion of points still landed close to the scatter-
plot diagonal, i.e. many sites are similarly scored even
by principally differing models (Figure 1C-F), there was
a considerable number of sequences with a significantly
higher score assigned by only one of the models, i.e.
displaying incompatible predictions of different models.Thus, a special interest was to determine whether these
sites were able to bind TFs in practice.
Experimental verification of predicted FoxA binding sites
by EMSA
Out of 466 BSs predicted in promoter regions, 64 were ar-
bitrarily selected for experimental verification by EMSA.
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ated by the models used (Figure 1). The main advantage
of EMSA is unambiguity in interpretation of the results.
This method records the fact of the TF binding to the
oligonucleotide corresponding to a predicted site, thereby
making it possible to set the threshold directly and restrict
the false-positives [3]. In this study, double-stranded oligo-
nucleotides for 64 selected FoxA sites were individually
added in ascending concentrations as cold competitors to
the binding reaction of labeled oligonucleotide corre-
sponding to a well-known FoxA site from mouse Ttr pro-
moter [28] with purified GST-FKH-FoxA2 protein. A
representative autoradiograph of separated complexes is
shown on Figure 2A.
Rough estimate of TFBS affinities relative to that of TTR
oligonucleotide were calculated (further referred to as the
EMSA scores listed in Additional file 1: Table S1). It was
found, that the distribution of estimated the EMSA scores
for 64 tested sites was essentially continuous (Figure 2B;Figure 2 Experimental verification of putative FoxA sites by EMSA. A
sites, with labeled TTR probe for binding to recombinant GST-FKH-FoxA2 (d
and 20 ng) of cold competitors are shown as triangles at the top of the fig
bottom. The band corresponding to the DNA-protein complex is marked by
positive and negative controls of protein binding. B – Distribution of EMSA sc
Selected BSs had peak height of at least 15 and were located in 1000 bp upst
and the number of sites predicted at a specific EMSA-score threshold. EMSA s
control site (referred to as the EMSA scores listed in Additional file 1: Table S1
(non-sites), 0.25 to 0.75 (weak sites) and above 0.75 (strong sites).Additional file 2: Figure S1), which agrees with the previ-
ous data for other TFs [29,30]. Based on the experimental
results, all the studied sequences were divided into three
groups: a) non-sites, EMSA scores below 0.25; b) weak
sites, EMSA scores from 0.25 to 0.75 and c) strong sites,
EMSA scores above 0.75 (Figure 1). Thus, the group of
non-sites consisted of sequences whose ability to bind to
GST-FKH-FoxA2 was not significantly different from the
unrelated sequence.
Comparison of the predictions and the experimental
data are shown in Figure 1. Most of the non-sites receive
low scores from all the models (the bottom left corner
in the scatterplots, Figure 1). In the case of the strong
and the weak sites the picture is different. As expected,
models of the same class (pairs oPWM/SiteGA and
ChIPMunk/diChIPMunk) predicted sites concentrating
in the top right corner of the scatterplot (Figure 1A,B),
i.e. the predictions were mostly consistent. At the same
time, predictions were less consistent for motif discovery– EMSA competition of oligonucleotides containing predicted FoxA
emonstrative autoradiographs). The ascending concentrations (2, 5,
ure, their IDs and resulting relative EMSA scores are shown at the
the arrow. Unlabeled TTR and PPAR oligonucleotides were used as
ores for 64 potential FoxA binding sites selected for EMSA verification.
ream regions of RefSeq genes. The X and Y axes denote the EMSA score
cores are rough estimates of TFBS affinities relative to that of the positive
). White, grey and black columns denote the EMSA scores below 0.25
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with high scores from one model and low scores from an-
other (Figure 1C-F), e.g. SiteGA versus ChIPMunk predic-
tions (Figure 1D). These models utilized different training
sets, and algorithms (SiteGA accounts for mutual depend-
encies between arbitrary positions, while ChIPMunk does
not). So, a combination of such fundamentally different
models can be the most effective in analyzing genome-
wide ChIP-Seq data.
For further analysis we selected EMSA score cutoff of
0.25, which allowed determination of the thresholds for
prediction models on a common basis (Figure 2). These
are 0.870, 0.848, 0.710 and 0.703 for ChIPMunk, diChIP-
Munk, SiteGA and oPWM, respectively. For each model,
we selected the threshold value as the highest score for
the subset of non-sites (Figure 1).
Identification of FoxA binding sites in genome-wide
ChIP-Seq data
Figure 3 shows scatterplots of scores of potential FoxA
sites predicted in all 4455 FoxA2-binding loci [24]. As for
the promoter regions, closely related models evaluated
most of the sites in a similar manner (Figure 3A,B),
whereas application of strongly differing approaches re-
sulted in a substantial fraction of sites scoring highly by
only one of them (Figure 3C-F). The use of thresholds,
determined by EMSA (Figure 3, black lines), allowed us to
discard sequences without threshold-passing predictions,
i.e. possibly not capable to bind FoxA directly. As a result,
SiteGA identifies 6884 reliable FoxA sites in 76.7% of
peaks, ChIPMunk – 7000 in 82.7% of peaks, and diChIP-
Munk– 6079 in 78.7% of peaks. However, only 3008 FoxA
sites in 45.1% of peaks are identified with oPWM ap-
proach, i.e. oPWM showed the weakest performance of all
four models. It is worth noting that combined use of the
models significantly increases the resulting number of the
peaks with the identified sites. As expected, among all
combinations the best was SiteGA/ChIPMunk with 90.0%
of peaks (10040 sites) with BSs recognized by at least one
model out of the pair. Another good combination was
diChIPMunk/SiteGA with 88.9% peaks (8985 sites). A de-
tailed analysis of SiteGA/ChIPMunk and diChIPMunk/
SiteGA results showed that the majority of ChIP-Seq peaks
contained more than one site (62.3% and 58.3%, respect-
ively). These results were in agreement with existing obser-
vations that FoxA prefers to bind to clusters of sites in the
regulatory regions of well-studied target genes [31-35].
The results show the high efficiency of the SiteGA
model, as well as both participants from pattern-
detection class (ChIPMunk and diChIPMunk). However,
since the latter models were trained on the same data as
used for the performance evaluation, the correct com-
parative assessment requires an additional independent
control ChIP-Seq dataset.Application of TFBS models to the control FoxA
ChIP-Seq dataset
The dataset described in [25] was taken as an independ-
ent control and contained 4367 FoxA2-binding loci, with
read coverage of at least 10. In this dataset SiteGA,
ChIPMunk, diChIPMunk and oPWM models recognized
5781 sites in 77.6% of peaks, 5629 sites in 81.5% of
peaks, 4892 sites in 76.6% of peaks, 2394 sites in 43.0%
of peaks respectively, showing almost the same perform-
ance as on Wederell’s data [24]. Note that oPWM again
had the worst prediction rate.
We expected the combination of models from different
classes (pattern matching and pattern detection) would be
more effective for analysis of genome-wide ChIP-Seq data.
To estimate performance of pairwise combinations of our
four models we computed the number of peaks with BSs
recognized by each pairs of models. The following cases
were separately processed: (a) peaks with at least one
(overlapping) BS predicted by two models, (b,c) peaks
with sites recognized by only one of the two models and
(d) peaks with only non-overlapping site predictions of by
two models (Figure 4). Note, that the total sum of these
fractions reflects the total number of peaks where at least
one site was found by any of the two tested models.
For all pairwise combinations the dependence of the
fraction of recognized peaks from the peak height cut-
off demonstrated a non-monotonic behavior, with sig-
nificant growth from approximately 50% of recognized
peaks at a cutoff value of 4 and a nearly uniform distri-
bution at cutoff values of 10 and higher. Basically, this
means that more erroneous peaks or weak sites are de-
tected near the lower peak height of 4, supporting the
choice of the peak height cutoff value of 10 for our
study.
The models from the same class (two pattern match-
ing or two pattern detection models) poorly complemen-
ted each other, giving a moderate rise in the number of
peaks with recognized BSs for the ChIPMunk/diChIP-
Munk pair (joint recognition 85.0% vs. 81.5/76.6% for sep-
arate models, respectively; Figure 4B) and almost no effect
for oPWM/SiteGA as SiteGA managed to recognize al-
most every peak detected by oPWM (joint recognition
78.2% vs. 77.6/43.0% for separate models, respectively;
Figure 4A).
On the contrary, the combination of pattern-matching
and pattern-detection models showed a substantial in-
crease in the number of peaks with recognized BSs.
Among all combinations the best again were SiteGA/ChIP-
Munk and SiteGA/diChIPMunk, with 90.7% and 89.1%
peaks recognized by at least one model out of a pair, re-
spectively (Figure 4C,D). More than a half of detected sites
were recognized by two models simultaneously: 58.1% of
sites (4679) and 58.9% (4196) for SiteGA/ChIPMunk and
diChIPMunk/SiteGA, respectively (Figure 4C,D, red). The
Figure 3 The scatterplots of scores of different FoxA BS recognition models for BSs derived from ChIP-Seq data [24]. Six panels from
A to F denote all possible pairwise combinations of ChIPMunk, diChIPMunk, SiteGA and oPWM models. Dots denote the subset of 49722
potential BSs that were mapped in ChIP-Seq peaks with heights of 15 and higher. Solid lines mark thresholds corresponding to the EMSA scores
below and above 0.25.
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were 9.1% for SiteGA and 13.1% for ChIPMunk (Figure 4C,
blue and green). For another combination, the respective
fractions were 11.5% for SiteGA and 12.5% for diChIP-
Munk (Figure 4D, blue and green). The fractions of simul-
taneously detected peaks with non-overlapped sites were8.9% and 8.4% (see Figure 4C,D, orange). A more detailed
analysis of SiteGA/ChIPMunk and diChIPMunk/SiteGA
results again shows that the majority of peaks contained
more than one site, 54.0% and 50.1% respectively. These
estimates are very similar to those computed above for
Wederell’s ChIP-Seq data [24].
Figure 4 The fraction of ChIP-Seq peaks [25] with recognized sites as a function of the peak height cut-off value. Six panels from A to F
denote predictions computed for all possible pairwise combinations of ChIPMunk, diChIPMunk, SiteGA and oPWM models. The X and Y axes
show the fraction of peaks having at least one FoxA binding site recognized by the respective model and the peak height cut-off value. The
panels from A to F show the comparisons between SiteGA and oPWM, ChIPMunk and diChIPMunk, SiteGA and ChIPMunk, SiteGA and diChIP-
Munk models, respectively. The following grouping of recognized TFBSs is used: loci with TFBSs recognized by both the first and second models
(e.g. D – SiteGA & ChIPMunk, respectively) that either overlap or not, are marked by RED and ORANGE, respectively; loci with at least one FoxA
binding site recognized by the first but not by the second model, or vice versa, are marked by GREEN and BLUE, respectively. Black vertical lines
denote the coverage threshold (peak height of 10).
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detected peaks with non-overlapping sites expected by
chance we performed a tenfold simulation on a random
1st order Markov chain background set that wasgenerated by shuffling full-length peaks. We count ob-
served and expected fractions of peaks with non-
overlapped sites among all peaks detected by two
models. For the SiteGA/ChIPMunk pair the expected
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12 according to the χ2 test for a 2×2 contingency table).
This provides evidence that these non-overlapping pre-
dictions are likely nonrandom and are due to heterogen-
eity of the FoxA BSs sequences and their preference to
form homotypic TFBS clusters.
Thus, usage of a pair of different models allowed both
an increase in the number of peaks with precisely posi-
tioned sites, and identification of multiple sites within a
single peak. The latter is quite important, since homotypic
clusters of TFBSs are often found in the gene regulatory
regions, underlying a number of mechanistic advantages
[36,37]. These may include favoring high-affinity coopera-
tive TF binding and lateral diffusion of TF binding along
regulatory regions, or simply increasing of the local TF
concentration in the vicinity of these regions and thereby
increase the probability of functional interactions [38-40].
Note that oPWM can also provide a benefit when
SiteGA is not available. For example, oPWM slightly in-
creased the number of peaks with detected BSs (4.6% only
oPWM, 43.1% only ChIPMunk, and 5.9% only oPWM,
39.5% only diChIPMunk, Figure 4E,F: blue and green) and
the number of peaks with non-overlapping sites detected
by different models (8.6% and 8.3%, Figure 4E,F, orange).
Comparison of constructed and existing FoxA TFBS
models
To compare the performance of the four models con-
structed in this study with known TFBS models we used
four additional PWMs: MA0047.2 [41] and MA0148.1
[42] from JASPAR [8], M01261 [43] and M01012 [44]
from TRANSFAC [7]. Among them only the latter was
not derived from ChIP-Seq data. Receiver operating
characteristic (ROC) curves were used to compare eight
models with Wallerman dataset [25] (Figure 5A). False
positive rates were estimated over the first order Markov
chain background-set that was generated by shuffling
full-length peak sequences. ROC curves close to the top
left corner correspond to the models with better per-
formance. Figure 5A clearly shows that the diChIPMunk
model outperformed all others ones. This seems to be a
consequence of the dinucleotide in contrast to mononu-
cleotide statistics used by other ChIP-Seq-derived
models. The TRANSFAC PWM M01012 showed the
worst performance. To compare other models in detail,
we computed the correlation coefficients (CC) that re-
flect the relationship between true and false positive
rates [45]. The CC values were computed for the EMSA-
based thresholds chosen earlier. EMSA thresholds for
additional models were selected as described above (see
Results section “Experimental verification of predicted
FoxA binding sites by EMSA”). The ChIPMunk, JASPAR
and M0148.1 matrices showed similar performance,
leaving TRANSFAC M01261 and JASPAR MA0047.2the worst among ChIP-Seq-derived models. Note that
the performance of SiteGA was on a par with those for
ChIP-Seq-derived models, outperforming other models
not derived from ChIP-Seq data, oPWM and TRANS-
FAC M01012. Thus SiteGA performed the best among
models not derived from ChIP-Seq data, most probably
because of its additional information relating distant se-
quence positions [12] (Figure 5A,B). To confirm that
the selected EMSA score 0.25 is appropriate, we per-
formed correlation coefficient calculations for two add-
itional EMSA score values 0.17 and 0.34 (Additional
file 2: Figure S2). One can see that for all models except
the worst one (TRANSFAC M01261) CC computed for
EMSA score 0.17 are notably lower than ones for EMSA
scores 0.25 and 0.34. Among the latter two that provide
similar CC values for nearly all models (Additional file 2:
Figure S2) the first EMSA score (0.25) was chosen as less
stringent.
We suspect that several factors are crucial in explain-
ing performance of different models (Figure 5): (a) the
training data-set, either ChIP-Seq derived or not; (b) a
visible improvement for conventional PWMs if dinucleo-
tide statistics are used along with extension of a matrix
length (diChIPMunk vs. ChIPMunk, oPWM vs. Transfac
PWM M01012); (c) accounting for possible distant de-
pendencies (SiteGA vs. oPWM).
Discussion
Computational methods of TFBS recognition provide
important tools to analyze ChIP-Seq data [1,46]. Many
different tools were presented for motif discovery in
ChIP-Seq data, including MEME-ChIP [47], RSAT peak-
motifs [48], Dimont [49]. Yet, it is commonly PWMs
from JASPAR and TRANSFAC that are applied for the
approval of ChIP-Seq data. A few attempts were made to
properly train complex models [50].
However, in the absence of additional experimental veri-
fication of TFBS models, it is difficult to estimate key
model parameters, such as recognition thresholds, which
would correctly separate true-positive from false-positive
predictions. Ignorance of these thresholds, in turn, greatly
complicates both the interpretation of ChIP-Seq data and
the performance comparison of TFBS-prediction methods.
Application of several models for TFBS prediction in
this study allowed us to resolve two important issues: (a)
whether advanced pattern match models (oPWM,
SiteGA), if properly trained on a limited curated TFBS
set, can compete with pattern discovery models (ChIP-
Munk, diChIPMunk) trained on ChIP-Seq data; and (b)
whether these advanced models can complement each
other or commonly applied PWMs (four additional rep-
resentatives from JASPAR and TRANSFAC were tested).
Using FoxA BSs as a case study, we have applied
EMSA to determine thresholds for eight models of TFBS
Figure 5 ROC (Receiver operating characteristic) of TFBS models (A) and CC (correlation coefficient) (B). A – ROC curves for 8 recognition
models applied to ChIP-Seq data [25]. ‘J’ - JASPAR PWM, ‘Tr’ - TRANSFAC PWM. The fraction of recognized peaks (X axis) shows the true positive
(TP) rate. The fraction of recognized shuffled peaks (Y axis) shows the false positive (FP) rate. Markers for each model show the point correspond-
ing to the EMSA-derived threshold. B – the correlation coefficients reflect balance between TP and FP rates computed for thresholds derived from
EMSA verification. The values of TP and TP rates are shown in ROC curves (A) by markers.
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of ChIP-Seq profiles for FoxA2 in adult mouse liver [24]
and in human HepG2 cells [25] allowed us to reliably
identify thousands of FoxA BSs within ChIP-Seq peaks
and to conduct an adequate comparison of the computa-
tional models studied.
First of all, in some cases models for TFBS recognition
are able to find trustworthy sites only in a small subset
of peaks, e.g. 29% for TRANSFAC M01012 and 43% for
oPWM (Figure 4A). This fraction is not what one should
expect from a TRANSFAC model, and only performing
the EMSA experiment allowed us to compute an accur-
ate estimate. Application of such models for finding
TFBSs in a major subset of ChIP-Seq peaks would re-
quire too low threshold value giving too many false posi-
tives. Hence, the threshold choice is the key point for
getting trustworthy TFBS-recognition results from
ChIP-Seq pipelines. It is important for different tasks,
e.g. identification of reliable TFBSs in ChIP-Seq data or
studying the ratio of direct and indirect protein binding
to chromatin. While EMSA was used here for selecting
thresholds, there could be other, less labor-intensive ap-
proaches, for example fluorescence correlation spectros-
copy (FCS) [51]. It is noteworthy that once experimental
verification is done for a particular protein, it could be
re-used for defining the thresholds for any correspond-
ing TFBS model and interpreting any ChIP-seq experi-
ment for this protein, as we have demonstrated on the
independent human FoxA2 ChIP-Seq dataset [25].
We conclude that models derived from ChIP-Seq usu-
ally outperformed the others. The important exception
is SiteGA, most probably due to its more complex algo-
rithm of information extraction and recognition. But this
outperformance does not diminish the value of themodels trained on independent data, which provide a
way to verify the results obtained from a ChIP-Seq
pipeline.
We have confirmed the supremacy of dinucleotide sta-
tistics for the TFBS models, showing its advantages for
both classes of methods. An important component of
this advantage comes from the informative data in the
flanking regions of the TFBS “core” sequence. The con-
sequence is typically longer matrix length, e.g. TRANS-
FAC M01012 (18 nt) vs. oPWM (32 nt) and ChIPMunk
(20 nt) vs. diChIPMunk (28 nt).
The models based on different principles complement
each other. Combined use of the models allowed better
identification of FoxA sites in corresponding ChIP-Seq
peaks. The best results for BS prediction in ChIP-Seq
data were achieved by model combinations, e.g. SiteGA
plus diChIPMunk, successfully identifying up to 90% of
FoxA BS-containing loci in both the mouse and human
ChIP-Seq data.
Conclusion
Nowadays ChIP-Seq is the gold standard for studying
TF-chromatin interactions in vivo. Detailed analysis of
TFBS in ChIP-Seq data requires validated computational
TFBS-recognition tools. The choice of the appropriate
thresholds for TFBS models is one of the key steps that
has been often underappreciated. We carried out an ex-
perimental study of FoxA binding to oligonucleotides,
corresponding to predicted sites. This allowed us to de-
termine the thresholds for several ChIP-Seq derived and
conventional models, improving their ability to predict
TFBSs. This also allowed us to compare models accur-
ately using the independent control ChIP-Seq dataset,
and conclude that (a) the weak ability to detect sites
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from ChIP-Seq in general are better than conventionally
derived pattern-match models, the latter valuably com-
plement the former in annotation of ChIP-Seq data; (c)
integration of different models allows detecting reliable
sites in up to 90% of ChIP-Seq loci.
Methods
Datasets and site prediction tools
Two publicly available ChIP-Seq datasets for FoxA2 TF
were used in this study: for adult mouse liver [24] (4455
mouse loci having base coverage no less than 15) and
for human HepG2 cells (4367 human loci with base
coverage no less than 10) [25]. The sequences were ex-
tracted from the mm8 and hg18 genome assemblies.
To train the pattern-matching models we gathered the
set of 53 known BSs (Additional file 1: Table S2) of FoxA
family TFs. The sequences were extracted from the
TRRD database [52] and by manual literature mining.
The selected BSs were confirmed by at least one of the
following methods: (1) DNase I footprinting using puri-
fied protein, (2) electrophoretic mobility shift assay
(EMSA) with purified protein, and (3) EMSA with nu-
clear extract and specific antibodies.
Sequences were aligned relative to the centrally located
pattern TRTTTRYH (R =A/G, Y = C/T, H =A/C/G) [13]
(Additional file 1: Table S2). The set of aligned sequences
was then used as the training set for the optimized PWM
(oPWM) and SiteGA models [12]. The construction of
oPWM included the search for the optimal matrix length
according to a resampling leave-one-out cross-validation
test (Additional file 2: Figure S3). The SiteGA model takes
into account statistical features of a binding site context
reflecting putative structural interactions within the
core and flanking regions of the site. It uses a genetic
algorithm with a discriminant function of locally posi-
tioned dinucleotide frequencies. The performance test
showed that the SiteGA model slightly outperformed
oPWM (Additional file 2: Figure S4).
ChIPMunk [19] is a fast heuristic DNA motif discovery
tool, which employs a greedy approach accompanied by
bootstrapping. It is able to properly use the ChIP-Seq base
coverage profile (the “peak shape”), producing high quality
motifs as shown in several independent benchmark stud-
ies [21-23,53]. ChIPMunk searches for the gapless mul-
tiple local alignment with the highest Kullback Discrete
Information Content (KDIC) [19], under the common as-
sumption of independence for neighboring nucleotides.
An improved version of the algorithm (diChIPMunk [20]),
uses a dinucleotide alphabet of 16 letters and the TFBS
model accounting for the dependence between nucleo-
tides in neighboring binding-site positions. A criterion for
the alignment optimality, Kullback Dinucleotide Discrete
Information Content (KDDIC), was constructed in thesame way as KDIC using a dinucleotides alphabet. The
matrix lengths for ChIPMunk and diChIPMunk were com-
puted by the jack-knife optimization procedure similar to
that for oPWM [12]. For ChIPMunk, diChIPMunk and
oPWM matrix scores were rescaled as described for
oPWM [12]. ChIPMunk trained on 4455 loci [24] resulted
in 20 nt mono- and 28nt dinucleotide matrices (Additional
file 2: Figure S5) which were in a good agreement with the
TRTTTRYH pattern, determined from our training set as
well as with the known FoxA binding consensus [54,55].
Plasmid construction and purification of GST fusion
protein
The FKH DNA-binding domain of FoxA2 (nt 432–869)
was amplified from rat genomic DNA by PCR using
primers DBD-FoxA2_f (5′-GCGGAATTCCGCTCGGG
ACCCCAAGACGTA-3′, EcoRI site is underlined) and
DBD-FoxA2_r (5′-GCGCTCGAGTCCCCGAGCTGAAC
CTGA-3′, XhoI site is underlined). The PCR product was
then digested with XhoI and EcoRI, and cloned into the
same sites of pGEX-4 T-1 vector (Pharmacia). The recom-
binant plasmid was transformed into E. coli BL21 cells by
electroporation. Expression of GST-fused FKH domain of
FoxA2 protein (GST-FKH-FoxA2) was induced by incuba-
tion with 0.1 mM isopropyl-β-D-thiogalactopyranoside for
3 h at 30°C. The GST-FKH-FoxA2 protein was purified
using a glutathione-sepharose (Sigma) column according
to the manufacturer’s protocol. The purity and size of the
eluted protein were evaluated by separation on SDS-
polyacrylamide gels and Coomassie Brilliant Blue staining.
EMSA
The double-stranded synthetic oligonucleotide probes
(containing predicted FoxA BSs) used for competition
EMSAs are listed in Additional file 1: Table S1. A double-
stranded TTR oligonucleotide containing a strong FoxA
binding site from the transthyretin promoter [26] was la-
beled by filling-in the sticky ends with Klenow enzyme
and [α-32P]dATP and used as DNA probe in EMSAs. In
the competitive experiments, 2, 5 and 20 ng of unlabelled
double-stranded oligonucleotide were added concurrently
with 1 ng of 32P-labeled TTR probe to the reaction mix-
tures containing 25 mM HEPES (pH 7.6), 150 mM KCl,
0.2 mM EDTA, 0.2 mM EGTA, 10% glycerol, 1 mM di-
thiothreitol and 3 μg of GST-FKH-FoxA2 protein and
allowed to incubate on ice for 15 min. Each gel run was
supplemented with TTR self-competition as a positive
control and a competition with PPAR oligonucleotide in
order to control for non-specific binding. Immediately fol-
lowing the incubation, the bound complexes were sepa-
rated from the free probe by electrophoresis on 4%
nondenaturing polyacrylamide gels in 0.5× Tris-borate-
EDTA buffer for 40 min at 4°C. After electrophoresis, the
gels were dried and visualized by autoradiography on
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tected and quantified using a Gel-Doc imaging system
and Quantity One software (Bio-Rad). The respective
concentration-response curves for each cold competitor
were subjected to log-transformation and linear regres-
sion and resulting slope values were normalized to that
of positive control (TTR self-competition) to achieve a
rough estimate of the relative FoxA2-binding strength
to the corresponding oligonucleotide (EMSA score,
Additional file 2: Figure S1). For all models the thresh-
old for “non-sites” was set at EMSA score 0.25 based
on the observed technical error multiplied by 1.5.Additional files
Additional file 1: Hyperlinks to ChIP-Seq datasets [24,25]; Table S1.
Double-stranded synthetic oligonucleotide probes used in competition
electrophoretic mobility shift assays (EMSAs) and their respective EMSA
scores; Table S2. Training data for SiteGA and oPWM models, aligned
FoxA BSs dataset, 53 BSs.
Additional file 2: Figure S1. EMSA score distribution. X axis shows
64 oligonucleotides (potential FoxAsites) that were chosen for EMSA
verification; oligonucleotides are shown in ascending order of EMSA
scores. Y axis shows EMSA scores. Figure S2. Correlation coefficients (CC)
for FoxA recognition models DiChIPMink, ChIPMunk, SiteGA, oPWM,
MA0047.2 [41] and MA0148.1 [42] from JASPAR [8], M01261 [43] and
M01012 [44] from TRANSFAC [7] FoxA recognition models. CC value were
computed as described previously [45] for thresholds of respective
recognition functions, selected to correspond EMSA score thresholds
0.17, 0.25 and 0.34. Higher CC value denotes better performance of a
model. X axis lists recognition models; Y axis shows CC values. Figure S3.
Recognition performance for dinucleotide PWMs as a function of a matrix
width. The X and Y (logarithmic scale) axes respectively show the length
of a matrix and a false-positive (FP) rate for a selected true-positive (TP)
rate (shown in figure legend). Figure S4. The comparison of recognition
performance between oPWM and SiteGA models. Both models are trained
on the same set of 53 FoxA binding sites (Additional file 1: Table S2). True
Positive (TP) and False Positive (FP) rates are fractions of training and back-
ground (shuffled) sets that were recognized at a selected threshold. The TP
and FP rates were evaluated by a standard leave-one-out cross-validation
test. Figure S5. Sequence LOGO representing TFBS models constructed
by ChIPMunk (top) and diChIPMunk (bottom). Mononucleotide LOGO
columns (top) are scaled according to a KDIC [19]. Dinucleotide motif LOGO
of the diChIPMunk motif shows frequencies for dinucleotides (bottom, scaled
according to a KDIDIC, [20]) formed by corresponding mononucleotide
columns (top, scaled according to the KDIC).Competing interests
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